Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05781750 |
| Consolidated Lead Sponsor | Kezar Life Sciences |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 84 participants (ACTUAL) |
| Registered Start Date | 2023-11-03 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Guangdong Provincial People's Hospital | Guangzhou, China | Open Hospital Dossier -> |
| ZhuJiang Hospital of Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
| Peking University Shenzhen Hospital | Shenzhen, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.